… ProQR Announces Results for the Second Quarter of 2016 … (NACFC)", said Daniel de Boer, Chief Executive Officer of ProQR. “For QR-110 for patients with LCA10, we presented … in this study include sweat chloride, weight gain, CFQ-R Respiratory Symptom Score and lung function, measured by …
… ProQR Announces Results for the First Quarter of 2016 LEIDEN, … pipeline", said Daniel de Boer, Chief Executive Officer of ProQR. “This quarter we organized an inaugural R&D Day where we, along with key opinion leaders presented …
… ProQR to Participate in the Kempen Life Sciences Conference … & CAMBRIDGE, Mass., April 19, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a … Kempen Life Sciences Conference on April 20, 2022. About ProQRProQR Therapeutics is dedicated to changing lives …
… ProQR Announces Participation in Upcoming Kempen Life … & CAMBRIDGE, Mass., April 22, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a … 2021 Thematic Virtual Series on April 28, 2021. About ProQRProQR Therapeutics is dedicated to changing lives …
… ProQR Announces Results for the Third Quarter of 2016 LEIDEN, the Netherlands, Nov. 14, 2016 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … said Daniel de Boer, Chief Executive Officer of ProQR “I’m proud of the team that has designed and executed …